In the first of our 2026 nitrosamine series webinars we discover how in silico solutions support the risk assessment and mitigation of nitrosamine formation in the drug product. Nitrosamine risk assessment within our solution Zeneth, evaluates a query compound and relevant excipients under a set of reaction conditions known to cause nitrosation reactions. In this case, the excipients and condition sets are pre-populated to predict reactions that the query compound could undergo, eliminating human error in the nitrosamine risk assessment workflow.
The presentation will include a real-life case study demonstrating our guest speakers from MircroLabs, use Zeneth to support nitrosamine risk assessment.